title: Prospects for prophylactic and therapeutic hepatitis C virus vaccines.
authors.affiliation: Chiron Corporation, Emeryville, California 94608, USA.
authors.forename: M
authors.initials: M
authors.lastname: Houghton
authors.forename: Q L
authors.initials: QL
authors.lastname: Choo
authors.forename: G
authors.initials: G
authors.lastname: Kuo
authors.forename: A
authors.initials: A
authors.lastname: Weiner
authors.forename: D
authors.initials: D
authors.lastname: Chien
authors.forename: R
authors.initials: R
authors.lastname: Ralston
authors.forename: M
authors.initials: M
authors.lastname: Urdea
authors.forename: B
authors.initials: B
authors.lastname: Moss
authors.forename: R
authors.initials: R
authors.lastname: Purcell
authors.forename: L
authors.initials: L
authors.lastname: Cummins
mesh_terms: D000818:Animals; D016174:Hepacivirus / Q000276:immunology*; D006526:Hepatitis C / Q000517:prevention & control*; D006801:Humans; D014614:Vaccines, Synthetic / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology* / Q000627:therapeutic use
chemical_list: D014614:Vaccines, Synthetic; D014765:Viral Vaccines